BioCentury
ARTICLE | Clinical News

Onyx, Bayer seeking to expand Nexavar label

June 4, 2013 2:56 AM UTC

Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) and Bayer AG (Xetra:BAYN) said they plan to submit an sNDA to FDA by mid-year for Nexavar sorafenib to treat radioactive iodine-refractory, differentiated thyro...